The Place of Thiothixene in the Treatment of Schizophrenic Patients

Ban T. A. : Psychopharmacology. Baltimore, The Williams and Wilkins Co., 1969.

Bartolucci G. : Clinical studies with clopenthixol (Sordinol) on chronic psychiatric patients. Curr. Ther. Res. 8: 581 (1966).

Bishop M. P. ; Fulmer T. E. and Gallant D. M. : Thiothixene versus trifluoperazine in newly admitted schizophrenic patients. Curr. Ther. Res. 8: 509 (1966).

Gallant D. M. ; Bishop M. P. and Shelton W. : A preliminary evaluation of P-4657B. A thioxanthene derivative. Amer. J. Psychiat. 123: 345 (1966).

Gallant D. M. : Thiothixene (P-4657B). A controlled evaluation in chronic schizophrenic patients. Curr. Ther. Res. 8: 153 (1966).

Gözsy B. and Kato L. : Maximal edema formation in rats provoked by minute amounts of dextran. Rev. Canad. Biol. 19: 425 (1960).

Kato L. and Gözsy B. : Kinetics of edema formation in rats as influenced by critical doses of dextran. Amer. J. Physiol. 199: 657 (1960).

Kato L. : Attempt to classify the psychotropic drugs based on their affinity to mucopolysaccharides in vivo. J. Clin. Exp. Psychopath. See Quart. Rev. Psychiat. Neurol. 23: 75 (1962).

Kurland A. A. and Yazicioglu E. : Effect of chlorprothixene on schizophrenic patients. Dis. Nerv. Syst. 22: 11 (1961).

Kurland A. A. : Pilot study of Navane (thiothixene) in chronic schizophrenics and psychotic patients. Curr. Ther. Res. 9: 298 (1967).

Lehmann H. E. and Ban T. A. : Studies with thioxanthenes. In: The Thioxanthenes (eds. Lehmann H. E. and Ban T. A. ). Basel, Karger, 1969.

Lehmann H. E. : The effects of haloperidol on acute schizophrenic patients. A comparative study of haloperidol, chlorpromazine and chlorprothixene. In: The Butyrophenones (eds. Lehmann H. E. and Bann T. A. ). Montreal, Q.P.R.A.

Lehmann H. E. : Potentiation of pharmacological and therapeutic actions of phenothiazines by nylidrin (Arlidin). Comprehens. Psychiat. 5: 36 (1964).

Oliveros R. F. : A clinical trial of thiothixene (Navane) in schizophrenics. Curr. Ther. Res. 9: 504 (1967).

Oliveros R. F. : Thiothixene — its range of therapeutic activity. Paper presented at the annual meeting of Canadian Society of Chemotherapy, Toronto, April 17 and 18, 1969.

Petersen P. V. : Chemical structure and pharmacological activity of the thioxanthene analogues of chlorpromazine, promazine and mepazine. Arzneim. Forsch. 8: 395 (1958).

Scheckel C. L. : Pharmacology and chemistry of the thioxanthenes with special reference to chlorprothixene. In: The Thioxanthenes (eds. Lehmann H. E. and Ban T. A. ). Basel, Karger, 1969.

Simeon J. : Clinical trial of Navane (thiothixene) in schizophrenia. Curr. Ther. Res. 9: 10 (1967).

Sterlin C. ; Oliveros R. and Ban T. A. : Predictors of therapeutic responsitivity to thiothixene in schizophrenics. Int. J. Clin. Pharmacol. 1: 5 (1968).

Sterlin C. : Psychometric and psychophysiological tests in the prediction of therapeutic responsiveness in the schizophrenias. Paper presented at the First International Congress of the C.I.A.N.S., Milan, October 18–20, 1968.

Warnes H. ; Cranfield Joyce and Ban T. A. : An uncontrolled study with thiothixene. In: The Thioxanthenes (eds. Lehmann H. E. and Ban T. A. ). Basel, Karger, 1969.

Weissman A. : A psychopharmacological comparison of thiothixene, chlorprothixene and clopenthixol in rats. In: The Thioxanthenes (eds. Lehmann H. E. and Ban T. A. ). Basel, Karger, 1969.

Wolpert A. ; Hagamen M. B. and Merlis S. : A pilot study of thiothixene in childhood schizophrenia. Curr. Ther. Res. 8: 617 (1966).